# Targetome profile of hsa-miR-93-5p is resistant to isoform formation in prostate adenocarcinoma

**Authors:** Anton Zhiyanov, Ivan Kirillov, Roman Suvorov, Diana Maltseva, Alexander Tonevitsky

PMC · DOI: 10.7717/peerj.20642 · PeerJ · 2026-02-16

## TL;DR

This study explores how the microRNA hsa-miR-93-5p and its isoforms regulate gene expression in prostate cancer, finding that they share many targets due to overlapping seed motifs.

## Contribution

The study reveals that hsa-miR-93-5p and its 5’-isomiRs share target transcripts due to co-occurring seed motifs, suggesting a dual-targeting mechanism.

## Key findings

- 5’-isomiRs of hsa-miR-93-5p share many targets with the canonical miRNA due to overlapping seed motifs in mRNAs.
- hsa-miR-93-5p ranks among miRNAs with the highest number of transcripts containing both canonical and shifted seed motifs.
- The study highlights a unique dual-targeting capacity of hsa-miR-93-5p in prostate adenocarcinoma.

## Abstract

MicroRNAs (miRNAs) and their isoforms, known as isomiRs, are important regulators of tumorigenesis that act as post-transcriptional modulators of gene expression. Among these, 5’-isomiRs—generated through imprecise cleavage during miRNA biogenesis—exhibit altered seed regions compared to their canonical counterparts, potentially leading to distinct targetomes. Consequently, 5’-isomiRs may exert biological functions that differ substantially from those of the corresponding canonical miRNAs. Despite growing recognition of their potential significance, the functional roles of 5’-isomiRs remain largely uncharacterized for most miRNAs. In this study, we investigated the targetome divergence between canonical miRNAs and their 5’-isomiRs, focusing on hsa-miR-93-5p, a miRNA with a well-established oncogenic role in prostate adenocarcinoma. Target transcripts of the 5’-isomiRs were identified using a shRNA-based overexpression system. Bioinformatic analysis revealed a substantial overlap between the targets of the 5’-isomiRs and the canonical miRNA. This overlap was attributed to the co-occurrence of both canonical and shifted seed motifs within the same mRNA targets. Notably, hsa-miR-93-5p ranked among the top miRNAs with a relatively high number of targets transcripts containing both seed motifs, suggesting a unique dual-targeting capacity.

## Linked entities

- **Diseases:** prostate adenocarcinoma (MONDO:0005082)

## Full-text entities

- **Genes:** MIR215 (microRNA 215) [NCBI Gene 406997] {aka MIRN215, miRNA215, mir-215}, MIR935 (microRNA 935) [NCBI Gene 100126325] {aka MIRN935, hsa-mir-935, mir-935}, PTPRH (protein tyrosine phosphatase receptor type H) [NCBI Gene 5794] {aka R-PTP-H, SAP1}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, MIR30A (microRNA 30a) [NCBI Gene 407029] {aka MIRN30A, mir-30a}, MIR1825 (microRNA 1825) [NCBI Gene 100302183] {aka MIRN1825, hsa-mir-1825}, FGFBP1 (fibroblast growth factor binding protein 1) [NCBI Gene 9982] {aka FGF-BP, FGF-BP1, FGFBP, FGFBP-1, HBP17}, MIR26B (microRNA 26b) [NCBI Gene 407017] {aka MIRN26B, hsa-mir-26b, miR-26b}, DROSHA (drosha ribonuclease III) [NCBI Gene 29102] {aka ETOHI2, HSA242976, RANSE3L, RN3, RNASE3L, RNASEN}, TRIM27 (tripartite motif containing 27) [NCBI Gene 5987] {aka RFP, RNF76}, MIR1915 (microRNA 1915) [NCBI Gene 100302129] {aka MIRN1915, hsa-mir-1915}, KRT75 (keratin 75) [NCBI Gene 9119] {aka CK-75, K6HF, K75, KB18, PFB, hK6hf}, MIR221 (microRNA 221) [NCBI Gene 407006] {aka MIRN221, miRNA221, mir-221}, PEAR1 (platelet endothelial aggregation receptor 1) [NCBI Gene 375033] {aka JEDI, MEGF12}, HNRNPC (heterogeneous nuclear ribonucleoprotein C) [NCBI Gene 3183] {aka HNRNP, HNRPC, MRD74, SNRPC}, PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 255738] {aka FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1}, AGO2 (argonaute RISC catalytic component 2) [NCBI Gene 27161] {aka CASC7, EIF2C2, LESKRES, LINC00980, PPD, Q10}, E2F1 (E2F transcription factor 1) [NCBI Gene 1869] {aka E2F-1, RBAP1, RBBP3, RBP3}, DICER1 (dicer 1, ribonuclease III) [NCBI Gene 23405] {aka DCR1, Dicer, Dicer1e, GLOW, HERNA, K12H4.8-LIKE}, AHNAK2 (AHNAK nucleoprotein 2) [NCBI Gene 113146] {aka C14orf78}, MIR93 (microRNA 93) [NCBI Gene 407050] {aka MIRN9, MIRN93, hsa-mir-93, miR-93}
- **Diseases:** tumorigenesis (MESH:D063646), type 2 diabetes (MESH:D003924), TNBC (MESH:D064726), breast tumor (MESH:D001943), prostate tumors (MESH:D011472), hepatocellular carcinoma (MESH:D006528), neurodegenerative disorders (MESH:D019636), metastasis (MESH:D009362), PCa (MESH:D011471), lung cancer (MESH:D008175), cardiovascular disease (MESH:D002318), cancer (MESH:D009369), Prostate Adenocarcinoma (MESH:D000230)
- **Chemicals:** L-glutamine (MESH:D005973), CO2 (MESH:D002245), glucose (MESH:D005947), poly(A) (MESH:D011061), penicillin (MESH:D010406), DMEM medium (-), hygromycin (MESH:C026273), AlexaFluor488 (MESH:C000711379), streptomycin (MESH:D013307), uracils (MESH:D014498)
- **Species:** Vesicular stomatitis virus (species) [taxon 11276], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PC-3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), DU-145 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0105), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), -93 — Homo sapiens (Human), Nephropathic cystinosis, Finite cell line (CVCL_CW96), HEK-293T — Homo sapiens (Human), Transformed cell line (CVCL_0063)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919312/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919312/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919312/full.md

---
Source: https://tomesphere.com/paper/PMC12919312